Stay updated on AK002 in Allergic Conjunctivitis Clinical Trial
Sign up to get notified when there's something new on the AK002 in Allergic Conjunctivitis Clinical Trial page.

Latest updates to the AK002 in Allergic Conjunctivitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for the completed Phase 1b AK002 study in patients with allergic conjunctivitis, including its study plan, participant criteria, outcome measures, and participating locations.SummaryDifference42%

- Check15 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces NIH’s website transition and says content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site revision label in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study page now displays a 403 error page, replacing the previous content with an access-denied screen. This signifies an access issue preventing users from viewing the trial information and related details.SummaryDifference16%

Stay in the know with updates to AK002 in Allergic Conjunctivitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 in Allergic Conjunctivitis Clinical Trial page.